含人極低密度脂蛋白受體基因的重組腺相關(guān)病毒的構(gòu)建
發(fā)布時間：2018-09-14 09:39
【摘要】： 目的構(gòu)建人的極低密度脂蛋白受體(VLDLR)基因,將其包裝成含VLDLR基因的重組腺相關(guān)病毒(rAAV-VLDLR),并檢測其滴度。方法通過設(shè)計含有特定酶切位點的引物,從人的骨骼肌中提取RNA,合成cDNA后,擴增人VLDLR全長基因的5’端約1000bp的DNA,并以含人VLDLR基因部分長的質(zhì)粒為模板,合成人VLDLR全長基因近3’端約1600bp的DNA,通過粘端連接將兩片段連接成全長VLDLR,并送基因公司檢測其與文獻報道的全長人VLDLR相符情況;將構(gòu)建的人VLDLR基因與重組腺相關(guān)病毒的真核表達載體PXXUF1連接,形成人VLDLR的重組腺相關(guān)病毒真核表達載體的重組體PXXUF1-VLDLR,鑒定后,將重組腺相關(guān)病毒系統(tǒng)的三種質(zhì)粒Pxx2、Phelper、PXXUF1-GFP(和PXXUF1-VLDLR)大量提取后純化,以293細胞作為細胞載體,利用磷酸鈣共轉(zhuǎn)染法包裝rAAV-VLDLR病毒與rAAV-GFP病毒,以rAAV-GFP病毒的包裝情況作為rAAV-VLDLR病毒包裝效率的參照,用斑點雜交的方法檢測兩種病毒的滴度。結(jié)果1、人極低密度脂蛋白受體基因構(gòu)建成功,與文獻報道基相符;2、PXXUF1-VLDLR構(gòu)建成功,rAAV-VLDLR病毒與rAAV-GFP病毒的滴度均為4×1011pfu/ml。結(jié)論用所構(gòu)建的人VLDLR基因包裝的rAAV-VLDLR病毒達到了要求的滴度,可用于后續(xù)糖尿病大鼠和細胞的相關(guān)研究。
[Abstract]:Objective To construct human very low density lipoprotein receptor (VLDLR) gene and package it into a recombinant adeno-associated virus (rAAV-VLDLR) containing VLDLR gene and detect its titer.Methods RNA was extracted from human skeletal muscle by designing primers containing specific enzyme digestion sites.After synthesizing the cDNA, the 5'-terminal DNA of the full-length gene of human VLDLR was amplified and the titer of the recombinant adeno-associated virus (rAAV-VLDLR) was determined. The human VLDLR gene was synthesized with a partial length plasmid containing human VLDLR gene as a template. The two fragments were ligated into a full length VLDLR by stick-end ligation and sent to the gene company to detect their conformity with the reported full-length human VLDLR gene. The constructed human VLDLR gene was compared with the recombinant adeno-associated virus eukaryotic expression vector PXXUF1. The recombinant adeno-associated virus eukaryotic expression vector PXXUF1-VLDLR was linked to form human VLDLR. After identification, three recombinant adeno-associated virus system plasmids Pxx2, Phelper, PXXUF1-GFP (and PXXUF1-VLDLR) were extracted and purified. 293 cells were used as cell carriers to package rAAV-VLDLR virus and rAAV-GFP disease by calcium phosphate co-transfection. Results 1. Human VLDLR gene was successfully constructed, which was consistent with the reported base. 2. PXXUF1-VLDLR was successfully constructed, and the titers of rAAV-VLDLR virus and rAAV-GFP virus were 4 *1011 pfu. Conclusion The rAAV-VLDLR virus packaged with the constructed human VLDLR gene has reached the required titer and can be used in the follow-up study of diabetic rats and cells.
【學(xué)位授予單位】：華中科技大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2007
【分類號】：R587.1;R346
本文編號：2242343
[Abstract]:Objective To construct human very low density lipoprotein receptor (VLDLR) gene and package it into a recombinant adeno-associated virus (rAAV-VLDLR) containing VLDLR gene and detect its titer.Methods RNA was extracted from human skeletal muscle by designing primers containing specific enzyme digestion sites.After synthesizing the cDNA, the 5'-terminal DNA of the full-length gene of human VLDLR was amplified and the titer of the recombinant adeno-associated virus (rAAV-VLDLR) was determined. The human VLDLR gene was synthesized with a partial length plasmid containing human VLDLR gene as a template. The two fragments were ligated into a full length VLDLR by stick-end ligation and sent to the gene company to detect their conformity with the reported full-length human VLDLR gene. The constructed human VLDLR gene was compared with the recombinant adeno-associated virus eukaryotic expression vector PXXUF1. The recombinant adeno-associated virus eukaryotic expression vector PXXUF1-VLDLR was linked to form human VLDLR. After identification, three recombinant adeno-associated virus system plasmids Pxx2, Phelper, PXXUF1-GFP (and PXXUF1-VLDLR) were extracted and purified. 293 cells were used as cell carriers to package rAAV-VLDLR virus and rAAV-GFP disease by calcium phosphate co-transfection. Results 1. Human VLDLR gene was successfully constructed, which was consistent with the reported base. 2. PXXUF1-VLDLR was successfully constructed, and the titers of rAAV-VLDLR virus and rAAV-GFP virus were 4 *1011 pfu. Conclusion The rAAV-VLDLR virus packaged with the constructed human VLDLR gene has reached the required titer and can be used in the follow-up study of diabetic rats and cells.
【學(xué)位授予單位】：華中科技大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2007
【分類號】：R587.1;R346
【參考文獻】
相關(guān)期刊論文 前7條
1 胡舜英;腺相關(guān)病毒在基因治療中的研究進展[J];國外醫(yī)學(xué).輸血及血液學(xué)分冊;2000年03期
2 屈伸,王劍波,劉志國,鄧耀祖,馮宗忱;中國人極低密度脂蛋白受體基因的克隆及其在中國倉鼠卵巢細胞中的表達[J];中國動脈硬化雜志;2000年03期
3 田俊,屈伸,王燕,李映紅,王宇哲,宗義強;極低密度脂蛋白受體在泡沫細胞形成中的作用地位[J];中國動脈硬化雜志;2004年05期
4 劉志國,屈伸;極低密度脂蛋白受體研究進展[J];中國生物化學(xué)與分子生物學(xué)報;2003年06期
5 過健俐,郭偉,姜立,張莉,屈伸;家兔極低密度脂蛋白受體的組織分布研究[J];同濟醫(yī)科大學(xué)學(xué)報;2001年05期
6 高凌,張木勛,鮑力,屈伸,李春蕊;極低密度脂蛋白受體在糖尿病患者脂肪組織中的分布和表達[J];中華內(nèi)分泌代謝雜志;2002年03期
7 李桂林,王任直,王欣,竇萬臣,張波,田士強,任祖淵,蘇長保;質(zhì)粒輔助重組腺病毒相關(guān)病毒的制備和純化[J];中華醫(yī)學(xué)雜志;2003年14期
，本文編號：2242343
本文鏈接：http://sikaile.net/yixuelunwen/binglixuelunwen/2242343.html
最近更新
教材專著
